717 results on '"Guddat, Luke W."'
Search Results
202. 9-[2-Hydroxy-3-(phosphonomethoxy)propyl] ("iso-HPMP") derivatives of purine bases and their side-chain modified analogues: synthesis and antimalarial activity
203. Acyclic nucleoside phosphonates as inhibitors of hypoxanthine-guanine-xanthine phosphoribosyltransferase: new anti-malarial chemotherapy leads
204. The organophosphate-degrading enzyme from Agrobacterium radiobacter displays mechanistic flexibility for catalysis
205. Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine–guanine–xanthine phosphoribosyltransferase
206. Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics
207. Conformational Changes in a Plant Ketol-Acid Reductoisomerase upon Mg2+ and NADPH Binding as Revealed by Two Crystal Structures
208. Crystal structures of free, IMP-, and GMP-bound Escherichia coli hypoxanthine phosphoribosyltransferase
209. Inhibition of purple acid phosphatase with α-alkoxynaphthylmethylphosphonic acids
210. Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle
211. Identification of a non-purple tartrate-resistant acid phosphatase: an evolutionary link to Ser/Thr protein phosphatases?
212. Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases.
213. Inhibition studies of purple acid phosphatases: implications for the catalytic mechanism
214. Lead Compounds for Antimalarial Chemotherapy: Purine Base Analogs Discriminate between Human and P. Falciparum 6-Oxopurine Phosphoribosyltransferases
215. Crystallization and preliminary X-ray analysis of a Kunitz-type inhibitor, textilinin-1 fromPseudonaja textilis textilis
216. Herbicide-binding sites revealed in the structure of plant acetohydroxyacid synthase
217. Crystallization and preliminary X-ray diffraction data for a purple acid phosphatase from sweet potato
218. Phosphate forms an unusual tripodal complex with the Fe–Mn center of sweet potato purple acid phosphatase
219. Probing the mechanism of the bifunctional enzyme ketol-acid reductoisomerase by site-directed mutagenesis of the active site
220. Facile crystallization ofEscherichia coliketol-acid reductoisomerase
221. Crystal structure and mechanism of a purple acid phosphatase from sweet potato: an enzyme with a novel Fe-Mn binuclear metal centre
222. Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties
223. Crystallization and preliminary diffraction studies of native and selenomethionine CcmG (CycY, DsbE)
224. Aza-acyclic Nucleoside PhosphonatesContaining a Second Phosphonate Group As Inhibitors of the Human, Plasmodium falciparumand vivax6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents.
225. Crystallization and preliminary X-ray diffraction data for a purple acid phosphatase from sweet potato
226. Crystallization and preliminary X-ray diffraction studies of mammalian purple acid phosphatase
227. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-γ-interferon antibody
228. Crystal structures of reduced and oxidized DsbA: investigation of domain motion and thiolate stabilization
229. Three-dimensional structure of a human Fab with high affinity for tetanus toxoid
230. Structural analysis of three His32 mutants of DsbA: Support for an electrostatic role of His32 in DsbA stability
231. The uncharged surface features surrounding the active site ofEscherichia coliDsbA are conserved and are implicated in peptide binding
232. Crystallographic Analysis of Antigen–Antibody Complexes: End-on Insertion of Ligands in Antibodies—CDR3 Loops as Arbiters
233. Intramolecular signaling upon complexation
234. Local and Transmitted Conformational Changes on Complexation of an Anti-sweetener Fab
235. Inhibitionof the Escherichia coli6-Oxopurine Phosphoribosyltransferasesby Nucleoside Phosphonates:Potential for New Antibacterial Agents.
236. AcyclicNucleoside Phosphonates Containing a SecondPhosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferasesand Have Antimalarial Activity.
237. Crystal Structures of Intact IgG Antibodies
238. Three-dimensional structure of an Fv from a human IgM immunoglobulin
239. Sulfonylureas Have AntifungalActivity and Are PotentInhibitors of Candida albicansAcetohydroxyacidSynthase.
240. Synthesis of Novel N-Branched Acyclic Nucleoside Phosphonates As Potent andSelective Inhibitors of Human, Plasmodium falciparumand Plasmodium vivax6-OxopurinePhosphoribosyltransferases.
241. Chemical Synthesis, in Vitro Acetohydroxyacid Synthase (AHAS) Inhibition, Herbicidal Activity, and Computational Studies of Isatin Derivatives.
242. Conformational Changes in a Plant Ketol-Acid Reductoisomerase upon Mg2+ and NADPH Binding as Revealed by Two Crystal Structures
243. Crystal structures of two novel sulfonylurea herbicides in complex with Arabidopsis thaliana acetohydroxyacid synthase.
244. Crystallization and preliminary X-ray analysis of a Kunitz-type inhibitor, textilinin-1 from Pseudonaja textilis textilis.
245. Structure-activity relationships for a new family of sulfonylurea herbicides.
246. Phosphate forms an unusual tripodal complex with the Fe -- Mn center of sweet potato purple acid phosphatase.
247. Crystal structures of free, IMP-, and GMP-bound Escherichia coli hypoxanthine phosphoribosyltransferase.
248. The structural and functional analysis of mycobacteria cysteine desulfurase-loaded encapsulin.
249. Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir)
250. The uncharged surface features surrounding the active site of Escherichia coli DsbA are conserved and are implicated in peptide binding.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.